Skip to main content
Top
Published in: Diabetologia 9/2013

Open Access 01-09-2013 | Article

Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α

Authors: A. Meerson, M. Traurig, V. Ossowski, J. M. Fleming, M. Mullins, L. J. Baier

Published in: Diabetologia | Issue 9/2013

Login to get access

Abstract

Aims/hypothesis

MicroRNAs (miRNAs) are short endogenous RNAs that regulate multiple biological processes including adipogenesis and fat metabolism. We sought to identify miRNAs that correlate with BMI and to elucidate their upstream regulation and downstream targets.

Methods

Microarray-based expression profiling of 233 miRNAs was performed on subcutaneous abdominal adipose tissue biopsies from 29 non-diabetic Pima Indian participants. Correlation of the expression levels of eight miRNAs with BMI was assessed by quantitative reverse transcription (QRT) PCR in adipose samples from 80 non-diabetic Pima Indians with a BMI of 21.6–54.0 kg/m2. The upstream regulation of one of these miRNAs, miR-221, was tested by treating cultured human pre-adipocytes with leptin, TNF-α and insulin. Predicted targets of miR-221 were validated using QRT-PCR, immunoblots and luciferase assays. The downstream effects of miR-221 overexpression were assayed by proteomic analysis.

Results

Expression levels of miR-221 were positively correlated with BMI (particularly in women) and fasting insulin concentrations, while the levels of miR-193a-3p and miR-193b-5p were negatively correlated with BMI; other miRNAs did not show significant associations in the 80 samples. miR-221 was downregulated by leptin and TNF-α treatment in cultured human pre-adipocytes. Conversely, miR-221 overexpression upregulated several proteins involved in fat metabolism, mimicking peroxisome proliferator-activated receptor (PPAR) activation. Furthermore, miR-221 directly downregulated the adiponectin receptor 1 (ADIPOR1) and the transcription factor v-ets erythroblastosis virus E26 oncogene homolog 1 (ETS1). Adiponectin signalling is known to promote insulin sensitivity, and ETS1 is crucial for angiogenesis.

Conclusions/interpretation

Our data suggest that miR-221 may contribute to the development of the insulin resistance that typically accompanies obesity, by affecting PPAR signalling pathways and by directly downregulating ADIPOR1 and ETS1.
Appendix
Available only for authorised users
Literature
1.
go back to reference Xie H, Sun L, Lodish HF (2009) Targeting microRNAs in obesity. Expert Opin Ther Targets 13:1227–1238PubMedCrossRef Xie H, Sun L, Lodish HF (2009) Targeting microRNAs in obesity. Expert Opin Ther Targets 13:1227–1238PubMedCrossRef
2.
go back to reference Heneghan HM, Miller N, Kerin MJ (2010) Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 11:354–361PubMedCrossRef Heneghan HM, Miller N, Kerin MJ (2010) Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 11:354–361PubMedCrossRef
3.
go back to reference Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R (2011) Diabetes mellitus, a microRNA-related disease? Transl Res 157:253–264PubMedCrossRef Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R (2011) Diabetes mellitus, a microRNA-related disease? Transl Res 157:253–264PubMedCrossRef
4.
go back to reference Karbiener M, Fischer C, Nowitsch S et al (2009) microRNA miR-27b impairs human adipocyte differentiation and targets PPARγ. Biochem Biophys Res Commun 390:247–251PubMedCrossRef Karbiener M, Fischer C, Nowitsch S et al (2009) microRNA miR-27b impairs human adipocyte differentiation and targets PPARγ. Biochem Biophys Res Commun 390:247–251PubMedCrossRef
5.
go back to reference Kim SY, Kim AY, Lee HW et al (2010) miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expression. Biochem Biophys Res Commun 392:323–328PubMedCrossRef Kim SY, Kim AY, Lee HW et al (2010) miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expression. Biochem Biophys Res Commun 392:323–328PubMedCrossRef
6.
go back to reference Ortega FJ, Moreno-Navarrete JM, Pardo G et al (2010) MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One 5:e9022PubMedCrossRef Ortega FJ, Moreno-Navarrete JM, Pardo G et al (2010) MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One 5:e9022PubMedCrossRef
7.
go back to reference Sun L, Xie H, Mori MA et al (2011) Mir193b–365 is essential for brown fat differentiation. Nat Cell Biol 13:958–965PubMedCrossRef Sun L, Xie H, Mori MA et al (2011) Mir193b–365 is essential for brown fat differentiation. Nat Cell Biol 13:958–965PubMedCrossRef
8.
go back to reference Zaragosi L-E, Wdziekonski B, Brigand K et al (2011) Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol 12:R64PubMedCrossRef Zaragosi L-E, Wdziekonski B, Brigand K et al (2011) Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol 12:R64PubMedCrossRef
9.
go back to reference Martinelli R, Nardelli C, Pilone V et al (2010) miR-519d overexpression is associated with human obesity. Obesity 18:2170–2176PubMedCrossRef Martinelli R, Nardelli C, Pilone V et al (2010) miR-519d overexpression is associated with human obesity. Obesity 18:2170–2176PubMedCrossRef
10.
go back to reference Fu T, Choi S-E, Kim D-H et al (2012) Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho. PNAS 109:16137–16142PubMedCrossRef Fu T, Choi S-E, Kim D-H et al (2012) Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho. PNAS 109:16137–16142PubMedCrossRef
11.
go back to reference Klöting N, Berthold S, Kovacs P et al (2009) MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One 4:e4699PubMedCrossRef Klöting N, Berthold S, Kovacs P et al (2009) MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One 4:e4699PubMedCrossRef
12.
go back to reference Herrera BM, Lockstone HE, Taylor JM et al (2010) Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 53:1099–1109PubMedCrossRef Herrera BM, Lockstone HE, Taylor JM et al (2010) Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 53:1099–1109PubMedCrossRef
13.
go back to reference Xie H, Lim B, Lodish HF (2009) MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58:1050–1057PubMedCrossRef Xie H, Lim B, Lodish HF (2009) MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58:1050–1057PubMedCrossRef
14.
go back to reference (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374–378PubMed (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374–378PubMed
15.
go back to reference Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
16.
go back to reference Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20PubMedCrossRef Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20PubMedCrossRef
17.
go back to reference Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27:91–105PubMedCrossRef Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27:91–105PubMedCrossRef
18.
go back to reference Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su J-L, Ringold GM (1997) TNFα-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARγ without effects on Pref-1 expression. Endocrinology 138:2776–2783PubMedCrossRef Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su J-L, Ringold GM (1997) TNFα-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARγ without effects on Pref-1 expression. Endocrinology 138:2776–2783PubMedCrossRef
19.
go back to reference Boersema PJ, Raijmakers R, Lemeer S, Mohammed S, Heck AJR (2009) Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat Protoc 4:484–494PubMedCrossRef Boersema PJ, Raijmakers R, Lemeer S, Mohammed S, Heck AJR (2009) Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat Protoc 4:484–494PubMedCrossRef
20.
go back to reference Bjørbaek C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305–331PubMedCrossRef Bjørbaek C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305–331PubMedCrossRef
21.
go back to reference Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409–2415PubMedCrossRef Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409–2415PubMedCrossRef
22.
go back to reference Könner AC, Brüning JC (2012) Selective insulin and leptin resistance in metabolic disorders. Cell Metab 16:144–152PubMedCrossRef Könner AC, Brüning JC (2012) Selective insulin and leptin resistance in metabolic disorders. Cell Metab 16:144–152PubMedCrossRef
23.
go back to reference Wauman J, Tavernier J (2011) Leptin receptor signaling: pathways to leptin resistance. Front Biosci 16:2771–2793CrossRef Wauman J, Tavernier J (2011) Leptin receptor signaling: pathways to leptin resistance. Front Biosci 16:2771–2793CrossRef
24.
go back to reference Czeh K, Winkler G, Melczer Z, Baranyi E (2000) The role of tumour necrosis factor (TNF)-alpha resistance in obesity and insulin resistance. Diabetologia 43:525–525CrossRef Czeh K, Winkler G, Melczer Z, Baranyi E (2000) The role of tumour necrosis factor (TNF)-alpha resistance in obesity and insulin resistance. Diabetologia 43:525–525CrossRef
25.
go back to reference Loh K, Fukushima A, Zhang X et al (2011) Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab 14:684–699PubMedCrossRef Loh K, Fukushima A, Zhang X et al (2011) Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab 14:684–699PubMedCrossRef
26.
go back to reference Berndt J, Kovacs P, Ruschke K et al (2007) Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 50:1472–1480PubMedCrossRef Berndt J, Kovacs P, Ruschke K et al (2007) Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 50:1472–1480PubMedCrossRef
27.
go back to reference Boden G (2011) Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18:139–143PubMedCrossRef Boden G (2011) Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18:139–143PubMedCrossRef
28.
go back to reference Capurso C, Capurso A (2012) From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol 57:91–97PubMedCrossRef Capurso C, Capurso A (2012) From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol 57:91–97PubMedCrossRef
29.
go back to reference Menendez JA, Vazquez-Martin A, Ortega FJ, Fernandez-Real JM (2009) Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem 55:425–438PubMedCrossRef Menendez JA, Vazquez-Martin A, Ortega FJ, Fernandez-Real JM (2009) Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem 55:425–438PubMedCrossRef
30.
go back to reference Olefsky JM, Saltiel AR (2000) PPAR gamma and the treatment of insulin resistance. Trends Endocrinol Metab 11:362–368PubMedCrossRef Olefsky JM, Saltiel AR (2000) PPAR gamma and the treatment of insulin resistance. Trends Endocrinol Metab 11:362–368PubMedCrossRef
31.
go back to reference Sugden MC, Holness MJ (2004) Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes 53(Suppl 1):S71–S81PubMedCrossRef Sugden MC, Holness MJ (2004) Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion. Diabetes 53(Suppl 1):S71–S81PubMedCrossRef
32.
go back to reference Yamauchi T, Kadowaki T (2013) Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab 17:185–196PubMedCrossRef Yamauchi T, Kadowaki T (2013) Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab 17:185–196PubMedCrossRef
33.
go back to reference Russell L, Garrett-Sinha LA (2010) Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine 51:217–226PubMedCrossRef Russell L, Garrett-Sinha LA (2010) Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine 51:217–226PubMedCrossRef
34.
go back to reference Shu CJ, Benoist C, Mathis D (2013) The immune system’s involvement in obesity-driven type 2 diabetes. Semin Immunol 24:436–442CrossRef Shu CJ, Benoist C, Mathis D (2013) The immune system’s involvement in obesity-driven type 2 diabetes. Semin Immunol 24:436–442CrossRef
35.
go back to reference Singh S, Barrett J, Sakata K, Tozer RG, Singh G (2002) ETS proteins and MMPs: partners in invasion and metastasis. Curr Drug Targets 3:359–367PubMedCrossRef Singh S, Barrett J, Sakata K, Tozer RG, Singh G (2002) ETS proteins and MMPs: partners in invasion and metastasis. Curr Drug Targets 3:359–367PubMedCrossRef
36.
go back to reference Chan YC, Roy S, Huang Y, Khanna S, Sen CK (2012) The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J Biol Chem 287:41032–41043PubMedCrossRef Chan YC, Roy S, Huang Y, Khanna S, Sen CK (2012) The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J Biol Chem 287:41032–41043PubMedCrossRef
37.
go back to reference Sung H-K, Doh K-O, Son JE et al (2013) Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metab 17:61–72PubMedCrossRef Sung H-K, Doh K-O, Son JE et al (2013) Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metab 17:61–72PubMedCrossRef
38.
go back to reference Sjøttem E, Rekdal C, Svineng G et al (2007) The ePHD protein SPBP interacts with TopBP1 and together they co-operate to stimulate Ets1-mediated transcription. Nucleic Acids Res 35:6648–6662PubMedCrossRef Sjøttem E, Rekdal C, Svineng G et al (2007) The ePHD protein SPBP interacts with TopBP1 and together they co-operate to stimulate Ets1-mediated transcription. Nucleic Acids Res 35:6648–6662PubMedCrossRef
39.
go back to reference Traurig MT, Permana PA, Nair S, Kobes S, Bogardus C, Baier LJ (2006) Differential expression of matrix metalloproteinase 3 (MMP3) in preadipocytes/stromal vascular cells from nonobese nondiabetic versus obese nondiabetic Pima Indians. Diabetes 55:3160–3165PubMedCrossRef Traurig MT, Permana PA, Nair S, Kobes S, Bogardus C, Baier LJ (2006) Differential expression of matrix metalloproteinase 3 (MMP3) in preadipocytes/stromal vascular cells from nonobese nondiabetic versus obese nondiabetic Pima Indians. Diabetes 55:3160–3165PubMedCrossRef
40.
go back to reference Kitamura S, Miyazaki Y, Hiraoka S et al (1999) PPARgamma inhibits the expression of c-MET in human gastric cancer cells through the suppression of Ets. Biochem Biophys Res Commun 265:453–456PubMedCrossRef Kitamura S, Miyazaki Y, Hiraoka S et al (1999) PPARgamma inhibits the expression of c-MET in human gastric cancer cells through the suppression of Ets. Biochem Biophys Res Commun 265:453–456PubMedCrossRef
41.
go back to reference Galardi S, Mercatelli N, Giorda E et al (2007) miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282:23716–23724PubMedCrossRef Galardi S, Mercatelli N, Giorda E et al (2007) miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282:23716–23724PubMedCrossRef
42.
go back to reference Zhao J-J, Lin J, Yang H et al (2008) MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283:31079–31086PubMedCrossRef Zhao J-J, Lin J, Yang H et al (2008) MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283:31079–31086PubMedCrossRef
43.
go back to reference Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A (2009) Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284:3728–3738PubMedCrossRef Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A (2009) Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284:3728–3738PubMedCrossRef
44.
go back to reference Zhang C-Z, Zhang J-X, Zhang A-L et al (2010) MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9:229PubMedCrossRef Zhang C-Z, Zhang J-X, Zhang A-L et al (2010) MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9:229PubMedCrossRef
45.
go back to reference Frenquelli M, Muzio M, Scielzo C et al (2010) MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27. Blood 115:3949–3959PubMedCrossRef Frenquelli M, Muzio M, Scielzo C et al (2010) MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27. Blood 115:3949–3959PubMedCrossRef
46.
go back to reference Pineau P, Volinia S, McJunkin K et al (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 107:264–269PubMedCrossRef Pineau P, Volinia S, McJunkin K et al (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 107:264–269PubMedCrossRef
47.
go back to reference Rao X, Di Leva G, Li M et al (2011) MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 30:1082–1097PubMedCrossRef Rao X, Di Leva G, Li M et al (2011) MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 30:1082–1097PubMedCrossRef
48.
go back to reference Trojanowska M (2000) Ets factors and regulation of the extracellular matrix. Oncogene 19:6464–6471PubMedCrossRef Trojanowska M (2000) Ets factors and regulation of the extracellular matrix. Oncogene 19:6464–6471PubMedCrossRef
49.
go back to reference Guijarro MV, Castro ME, Romero L, Moneo V, Carnero A (2007) Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest. J Cell Biochem 101:112–121PubMedCrossRef Guijarro MV, Castro ME, Romero L, Moneo V, Carnero A (2007) Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest. J Cell Biochem 101:112–121PubMedCrossRef
50.
go back to reference Antoon JW, Lai R, Struckhoff AP et al (2012) Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance. Sci Rep 2:539PubMedCrossRef Antoon JW, Lai R, Struckhoff AP et al (2012) Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance. Sci Rep 2:539PubMedCrossRef
51.
go back to reference Nakamura Y, Esnault S, Maeda T, Kelly EAB, Malter JS, Jarjour NN (2004) Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts. J Immunol 172:1945–1952PubMed Nakamura Y, Esnault S, Maeda T, Kelly EAB, Malter JS, Jarjour NN (2004) Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts. J Immunol 172:1945–1952PubMed
Metadata
Title
Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α
Authors
A. Meerson
M. Traurig
V. Ossowski
J. M. Fleming
M. Mullins
L. J. Baier
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 9/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2950-9

Other articles of this Issue 9/2013

Diabetologia 9/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.